A Florida State University computational scientist is paving the way for future medical breakthroughs by developing ...

Lymphomas, a group of heterogeneous malignancies, are among the leading causes of cancer-related mortality worldwide 1. Lymphomas account for approximately 5% of malignancies with an estimated ...

Targeted drug delivery has long been a cornerstone goal of modern medicine—sending therapies exactly where they’re needed while sparing healthy tissues. Yet creating treatments that can decide when ...

Despite recent advances in targeted drug delivery, approved Antibody-Drug-Conjugates (ADCs) are still limited by the delivery of a restricted set of payloads with limited modes of action (MOA).

Rising Adoption of Precision Medicine, Expanding ADC Success, and Advanced Targeted Delivery Technologies Are Accelerating ...

This technology has the potential to advance new immunotherapy approaches for patients with significant unmet medical ...

Scientists headed by a team at the University of British Columbia (UBC) have developed a new approach to drug design that can deliver therapeutics directly to a specific part of the gastrointestinal ...

Fabricated with a gel side for carrying drugs and a magnetic side for steering, these microrobots can navigate complex biological environments like intestines. Microrobots formed in droplets could ...

Researchers have demonstrated that microscopic drug delivery containers can be magnetically steered to their targets, advancing the development of precision medicine for treating diseases such as ...

Neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), motor neuron disease (MND, including amyotrophic lateral sclerosis, (ALS)), and frontotemporal dementia (FTD) ...

A new antibody‑drug conjugate nearly doubles survival and extends overall survival in advanced triple‑negative breast cancer, ...